Solventum Corp. Files 8-K
Ticker: SOLV · Form: 8-K · Filed: Dec 16, 2025 · CIK: 1964738
| Field | Detail |
|---|---|
| Company | Solventum Corp (SOLV) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, spin-off, legal-entity
TL;DR
Solventum Corp (formerly 3M Health Care) officially filed its 8-K, confirming Delaware incorporation and MN HQ.
AI Summary
Solventum Corporation, formerly 3M Health Care Co., filed an 8-K on December 16, 2025. The filing indicates Solventum is incorporated in Delaware and its principal executive offices are located at 3M Center, Maplewood, Minnesota. The company's IRS Employer Identification Number is 92-2008841, and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides essential corporate identity and structural information for Solventum Corporation, a newly independent entity spun off from 3M.
Risk Assessment
Risk Level: low — This is a routine corporate filing providing basic information and does not contain market-moving financial data or strategic announcements.
Key Numbers
- 92-2008841 — IRS Employer Identification No. (Unique identifier for tax purposes.)
- 001-41968 — SEC File Number (SEC registration identifier.)
Key Players & Entities
- Solventum Corporation (company) — Registrant
- 3M Health Care Co. (company) — Former Name
- 3M (company) — Parent Company (former)
- Delaware (jurisdiction) — State of Incorporation
- Maplewood, Minnesota (location) — Principal Executive Offices Location
- December 16, 2025 (date) — Date of Report
FAQ
What is the exact name of the registrant?
The exact name of the registrant is Solventum Corporation.
In which state is Solventum Corporation incorporated?
Solventum Corporation is incorporated in Delaware.
What is the address of Solventum Corporation's principal executive offices?
The address of Solventum Corporation's principal executive offices is 3M Center, Building 275-6W, East, Maplewood, Minnesota 55144.
What was the former name of Solventum Corporation?
The former name of Solventum Corporation was 3M Health Care Co.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 16, 2025.
Filing Stats: 537 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-12-16 09:02:04
Filing Documents
- solv-20251216.htm (8-K) — 26KB
- solvdecember2025shareholde.htm (EX-99.1) — 7KB
- 0001964738-25-000094.txt ( ) — 151KB
- solv-20251216.xsd (EX-101.SCH) — 2KB
- solv-20251216_lab.xml (EX-101.LAB) — 22KB
- solv-20251216_pre.xml (EX-101.PRE) — 13KB
- solv-20251216_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure On December 16, 2025, Solventum Corporation issued a letter to its shareholders. A copy of the shareholder letter is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information contained in Item 7.01 and attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall such information and exhibit be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Letter to Shareholders, December 16, 2025 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SOLVENTUM CORPORATION By: /s/ Wayde McMillan Wayde McMillan Executive Vice President and Chief Financial Officer Dated: December 16, 2025